改良全球疾病负担国际疾病分类编码方法识别脓毒症的准确性:一项前瞻性多中心队列研究
该前瞻性多中心观察研究在澳大利亚新南威尔士州9家医院急诊科筛查≥16岁高脓毒症风险患者,用Sepsis 3标准临床诊断脓毒症,并比较三种改良GBD ICD编码方法与Angus法的识别准确性。450例纳入患者中临床脓毒症215/450(47.8%);显式法、隐含法、隐含加号法和Angus法分别识别108/450(24.0%)、175/450(38.9%)、222/450(49.3%)和170/450(37.8%),敏感性分别为41.4%、58.1%、67.4%和55.8%,特异性分别为91.9%、78.7%、67.2%和79.1%。所有ICD编码方法与临床脓毒症的一致性均低(Cronbach α=0.52–0.56)。假阳性主要涉及未特指尿路感染、低血压和急性肾衰竭编码,假阴性中约44.3%–55.6%未记录病原体。
要点
- 在急诊≥16岁高脓毒症风险患者中,改良GBD的隐含加号法识别脓毒症最准,敏感性67.4%、特异性67.2%,但仍漏诊近三分之一临床脓毒症。
- 显式法敏感性仅41.4%、特异性91.9%;隐含法敏感性58.1%、特异性78.7%;Angus法敏感性55.8%、特异性79.1%。
- 三种改良GBD方法与临床脓毒症的一致性均低(Cronbach α=0.52–0.56),ICD编码不能替代床旁Sepsis 3临床诊断。
- 假阳性主要来自未特指尿路感染、低血压和急性肾衰竭的感染与器官功能障碍编码。
- 假阴性中约44.3%–55.6%的病例未记录病原体。
适用人群与场景
- 澳大利亚新南威尔士州9家医院急诊科就诊、年龄≥16岁、高脓毒症风险的患者。
- 采用Sepsis 3标准进行临床脓毒症判定。
诊断标准与关键阈值
- 临床脓毒症诊断采用Sepsis 3标准。
- 改良GBD显式法:记录有脓毒症特异性ICD编码。
- 改良GBD隐含法:脓毒症特异性编码或感染作为主要ICD编码 plus 器官功能障碍编码。
- 改良GBD隐含加号法:同隐含法,但感染作为主要或次要ICD编码。
- 对照方法为Angus法。
研究设计与关键结果
- 研究类型为前瞻性多中心观察性研究,纳入450例(中位年龄72.4岁,女性48.9%),临床脓毒症215/450(47.8%)。
- 显式法识别脓毒症108/450(24.0%),敏感性41.4%,特异性91.9%。
- 隐含法识别脓毒症175/450(38.9%),敏感性58.1%,特异性78.7%。
- 隐含加号法识别脓毒症222/450(49.3%),敏感性67.4%,特异性67.2%。
- Angus法识别脓毒症170/450(37.8%),敏感性55.8%,特异性79.1%。
- 所有ICD编码方法与临床脓毒症的一致性均低(Cronbach α=0.52–0.56)。
- 显式法、隐含法、隐含加号法的假阳性分别为19、50、77例,假阴性分别为126、90、70例。
- 假阳性病例中常见的感染和器官功能障碍编码为未特指尿路感染、低血压和急性肾衰竭。
证据类型、等级与局限
- 证据类型:前瞻性多中心观察性队列研究。
- 试验注册:ANZCTR(ACTRN12621000333819),注册日期2021年3月24日。
- 局限:原文未报告局限性。
对床旁实践的改变
- 研究显示改良GBD的ICD编码方法识别脓毒症准确性低,其中隐含加号法最准确,但ICD编码结果不能替代急诊床旁Sepsis 3临床诊断。
- 使用ICD编码识别脓毒症时,需注意未特指尿路感染、低血压和急性肾衰竭编码可能造成假阳性,未记录病原体可能造成假阴性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: This study assessed the accuracy of three International Classification of Diseases (ICD) codes methods derived from Global Burden of Disease (GBD) sepsis study (modified GBD method) in identifying sepsis, compared to the Angus method. Sources of errors in these methods were also reported.
METHODS: Prospective multicentre, observational, study. Emergency Department patients aged ≥ 16 years with high sepsis risk from nine hospitals in NSW, Australia were screened for clinical sepsis using Sepsis 3 criteria and coded as having sepsis or not using the modified GBD and Angus methods. The three modified GBD methods were: Explicit-sepsis-specific ICD code recorded; Implicit-sepsis-specific code or infection as primary ICD code plus organ dysfunction code; Implicit plus-as for Implicit but infection as primary or secondary ICD code. Agreement between clinical sepsis and ICD coding methods was assessed using Cronbach alpha (α). For false positive cases (ICD-coded sepsis but not clinically diagnosed), the ICD codes leading to those errors were documented. For false negatives (clinically diagnosed sepsis but ICD-coded), uncoded sources of infection and organ dysfunction were documented.
RESULTS: Of 6869 screened patients, 450 (median age 72.4 years, 48.9% females) met inclusion criteria. Clinical sepsis was diagnosed in 215/450 (47.8%). The explicit, implicit, implicit plus and Angus methods identified sepsis in 108/450 (24.0%), 175/450 (38.9%), 222/450 (49.3%) and 170/450 (37.8%), respectively. Sensitivity was 41.4%, 58.1%, 67.4% and 55.8%, and specificity 91.9%, 78.7%, 67.2% and 79.1%, respectively. Agreement between clinical sepsis and all ICD coding methods was low (α = 0.52-0.56). False positives were 19, 50, and 77, while false negatives were 126, 90, and 70 for the explicit, implicit, and implicit plus methods, respectively. For false positive cases, unspecified urinary tract infection, hypotension and acute kidney failure were commonly assigned infection and organ dysfunction codes. About half (44.3%-55.6%) of the false negative cases didn't have a pathogen documented.
CONCLUSION: The modified GBD method demonstrated low accuracy in identifying sepsis; with the implicit plus method being the most accurate. Errors in identifying sepsis using ICD codes arise mostly from coding for unspecified urinary infections and associated organ dysfunction.
TRIAL REGISTRATION: The study was registered at the ANZCTR (ACTRN12621000333819) on 24 March 2021.
参考来源
- Kumar A, Venkatesh B, Finfer S, et al. Accuracy of the modified Global Burden of Disease International Classification of Diseases coding methods for identifying sepsis: a prospective multicentre cohort study. Crit Care. 2025. PMID: 40457465. doi:10.1186/s13054-025-05448-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。